The following articles are being highlighted as part of Circulation's Topic Review series. This series will summarize the most important manuscripts, as selected by the editors, published in Circulation and the Circulation subspecialty journals. The studies included in this article represent the most read manuscripts published on the topic of epidemiology and prevention in . (Circulation. 2011124:e520-e533.) Correspondence to The Editors, Circulation Editorial Office, Summary: Inflammatory factors, adipocytokines, and the metabolic syndrome are important determinants of cardiometabolic disease. It remains unknown whether physical activity, a key modifiable factor for cardiometabolic disease control and prevention, may modify these cardiovascular risk factors. We analyzed single and joint associations of physical activity, inflammatory factors, adipocytokines, and the metabolic syndrome among 3289 Chinese people 50 to 70 years of age who participated in a cross-sectional survey in Beijing and Shanghai in 2005. Levels of total physical activity were assessed with the International Physical Activity Questionnaire. Inflammatory factors (high-sensitivity C-reactive protein, interleukin-6, and tumor necrosis factor-␣ receptor 2) and adipocytokines (adiponectin and retinol-binding protein 4) were measured. The metabolic syndrome was defined according to the National Cholesterol Education Program/Adult Treatment Panel III criteria for Asian Americans. In multivariable regression analyses, high levels of total physical activity were significantly associated with a 20% lower level of high-sensitivity C-reactive protein, 7% higher level of adiponectin, and 30% lower risk of having the metabolic syndrome compared with those with low levels. Importantly, higher levels of physical activity were associated with a lower likelihood of having the metabolic syndrome even among individuals with adverse levels of inflammatory factors or adipocytokines. Even moderate-intensity activities were related to the health benefits. Public health recommendations to promote moderate-to vigorous-intensity activities may help to curtail the current epidemic of cardiometabolic disorders in Chinese people.
Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women
Summary: Prior studies have clearly established the independent role of arterial hypertension in the pathogenesis of atrial fibrillation, but optimal blood pressure levels for atrial fibrillation prevention have not been defined. We therefore assessed in detail the relationship of systolic and diastolic blood pressure levels and the risk of incident atrial fibrillation among 34 221 middle-aged, initially healthy women. During a median follow-up of 12.4 years, we confirmed 644 events. Our findings show that both systolic (P for trend Ͻ0.0001) and diastolic (P for trendϭ0.004) blood pressures were independently associated with incident atrial fibrillation. We also found that women with nonhypertensive systolic (130 -139 mm Hg) or diastolic (85-89 mm Hg) blood pressure levels had a 28% and 53% increased risk of incident atrial fibrillation compared with women with systolic blood pressure Ͻ120 mm Hg or diastolic blood pressure Ͻ65 mm Hg, respectively. These results were similar when we took into account blood pressure changes over time. Taken together, the tight association between blood pressure, incident atrial fibrillation, and subsequent cardiovascular events suggests that future hypertension guidelines may assign a more important role to atrial fibrillation for cardiovascular risk stratification in patients with hypertension. Our findings also indicate that tight blood pressure control may help to reduce the growing burden of atrial fibrillation in the community.
Conclusions:
In this large cohort of initially healthy women, blood pressure (BP) was strongly associated with incident atrial fibrillation, and systolic BP was a better predictor than diastolic BP. Systolic BP levels within the nonhypertensive range were independently associated with incident AF even after BP changes over time were taken into account. 1
Declining Severity of Myocardial Infarction From 1987 to 2002: The Atherosclerosis Risk in Communities (ARIC) Study
Summary: Death rates for coronary heart disease have been declining in the United States. From a public health standpoint, it is important to identify factors that are contributing to this decline. We investigated whether a reduction in severity of myocardial infarction may contribute to lower death rates. We tracked residents 35 to 74 years of age in the community surveillance component of the Atherosclerosis Risk in Communities (ARIC) Study who were hospitalized with acute incident myocardial infarction and looked at severity indicators abstracted from hospital charts. Included in these were ECG, biomarker, and hemodynamic indicators. With few exceptions, the myocardial infarction severity indicators suggested a significant decline in the severity of myocardial infarction during the period of 1987 to 2002. This reduction in severity may have contributed, along with other factors, to the decline in death rates. There may be several reasons for a decline in severity of incident myocardial infarction; the findings from the present study suggest that 1 factor may be better primary prevention and support ongoing research to determine how preventive care may further reduce coronary heart disease death.
Conclusions: Evidence from ARIC community surveillance suggests that the severity of acute myocardial infarction has declined among community residents hospitalized for incident myocardial infarction. This reduction in severity may have contributed, along with other factors, to the decline in death rates for coronary heart disease. 2
Risk Factors for Venous Thromboembolism: Results From the Copenhagen City Heart Study
Summary: Deep vein thrombosis and pulmonary embolism are often viewed as 1 disease denoted venous thromboembolism (VTE), which is the cause of considerable morbidity and mortality. VTE and atherosclerotic disease such as acute myocardial infarction have for many years been considered 2 different disease entities with important differences in their pathways to thrombosis and hence in their preventive measures. Recent studies, however, have disputed this, among these a large clinical trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin [JUPI-TER]) showing an impressive lowering of VTE incidence with statin treatment. In this hitherto largest study, we studied common risk factors for atherosclerotic disease to determine whether these were also associated with VTE but found that only obesity and smoking were important risk factors for VTE, whereas total/high-density lipoprotein/low-density lipoprotein cholesterol levels, triglyceride levels, and diabetes mellitus were not. This would indicate that any beneficial effect of statins on VTE is through pleiotropic mechanisms and that treatment of dyslipidemia in itself may be of low value for preventing VTE. Conversely, management of obesity and smoking cessation are likely to be beneficial for both VTE and atherosclerotic disease.
Conclusions: Obesity and smoking were both found to be important risk factors for VTE whereas total/high-density lipoprotein/lowdensity lipoprotein cholesterol levels, triglyceride levels, and diabetes mellitus were not. 3 
Burden of Cardiovascular Risk Factors, Subclinical Atherosclerosis, and Incident Cardiovascular Events Across Dimensions of Religiosity: The Multi-Ethnic Study of Atherosclerosis
Summary: A variety of behaviors can benefit or harm one's cardiovascular health, and it has been observed that religious beliefs and practices may influence one's health behaviors significantly. We sought to determine whether and to what extent different aspects of religiosity may be associated with cardiovascular health. Using a large, ethnically diverse, community-based sample of men and women ages 45 to 84 years who were asymptomatic at baseline, we compared the prevalence of cardiovascular risk factors, the presence and burden of subclinical cardiovascular disease, and the incidence of cardiovascular events across different levels of religiosity. We adjusted for sociodemographic factors to ensure that these potential confounders were not responsible for associations found between religion and cardiovascular health. We observed that those who attended services frequently and those who prayed frequently were significantly less likely to smoke than those who never attended services or prayed. Perhaps more surprisingly, we found that frequent service attendees and those who prayed often were significantly more likely to be obese. We did not observe any significant associations between religiosity and presence/extent of subclinical disease or incident cardiovascular events. The consistent and significant association found between religiosity and obesity in this cross-sectional study raises some interesting questions. What is the temporal nature of the association? If being more religious makes one more likely to be obese, then why does this occur? Ultimately, this observation should encourage inter-action between healthcare providers, public health officials, and the religious community in an effort to improve obesity education and prevention.
Conclusions: Our results do not confirm those of previous studies associating greater religiosity with overall better health risks and status, at least with regard to cardiovascular disease. There was no reduction in risk for cardiovascular disease events associated with greater religiosity. 5
Conventional Cardiovascular Risk Factors and Metabolic Syndrome in Predicting Carotid Intima-Media Thickness Progression in Young Adults: The Cardiovascular Risk in Young Finns Study
Summary: Accelerated progression in carotid intima-media thickness (IMT) is a marker of atherosclerosis development that is associated with increased risk of cardiovascular events. Exposure to elevated cardiovascular risk factor levels and the metabolic syndrome has been shown to predict increased IMT. However, limited longitudinal data are available on the association of risk factors and metabolic syndrome with IMT progression in young adults. On the basis of a large, population-based study of young adults (nϭ1809; aged 24 -39 years), our results suggest a pathophysiological role of obesity, dyslipidemia, and hyperinsulinemia in predicting atherosclerosis development. In addition, the diagnosis of metabolic syndrome may be helpful in identifying groups of individuals who have accelerated progression of carotid IMT. However, we found no evidence to suggest that metabolic syndrome would predict IMT progression more than would be expected from the sum of its risk components. As shown in our study, adverse developments of lifestyles leading to obesity are translated into accelerated atherosclerosis early in adult life. Therefore, in addition to identification of individuals who are at particularly high risk, a major effort is needed for the reduction of obesity in the entire population of children, adolescents, and young adults to reduce the burden of cardiovascular disease late in their life.
Conclusions: Obesity, high low-density lipoprotein cholesterol, and high insulin level predicted IMT progression in young adults. All MetS definitions identified young adults with accelerated IMT progression, but we found no evidence that MetS would predict IMT progression more than expected from the sum of its risk components. 6
Pericardial Fat, Intrathoracic Fat, and Measures of Left Ventricular Structure and Function: The Framingham Heart Study
Summary: Pericardial fat, or fat that surrounds the heart, may be associated with obesity-related cardiovascular disease. We explored whether the associations of pericardial fat and measures of cardiac structure and function are linked. We measured pericardial fat in participants from the Framingham Heart Study and assessed measures of cardiac structure and function. We found that multiple different measures of fat were associated with cardiac measures of structure and function, but none persisted after accounting for overall body weight and visceral abdominal fat, the most metabolically active fat depot. An important exception was the relation of pericardial fat and left atrial dimension in men. These results suggest that the systemic effects of obesity on cardiac structure and function may outweigh the local pathogenic effects of pericardial fat.
Conclusions: Pericardial fat is correlated with cardiovascular magnetic resonance measures, but the association is not independent of or stronger than other ectopic fat stores or proxy measures of visceral adiposity. An important exception is left atrial dimension in men. These results suggest that the systemic effects of obesity on cardiac structure and function may outweigh the local pathogenic effects of pericardial fat. 7
Thirty-Year Trends (1975-2005) in the Magnitude of, Management of, and Hospital Death Rates Associated With Cardiogenic Shock in Patients With Acute Myocardial Infarction: A Population-Based Perspective
Summary: The results of this population-based epidemiological study demonstrate that cardiogenic shock remains a relatively frequent complication of acute myocardial infarction, affecting Ϸ1 in every 15 patients hospitalized with acute myocardial infarction. Although the incidence rates of cardiogenic shock have remained relatively stable over the past 30 years (1975-2005) in our investigation of residents of a large New England metropolitan area hospitalized with acute myocardial infarction at all area medical centers, encouraging improvements in the hospital survival of these high-risk patients have occurred coincidentally with the increasingly aggressive management of patients who developed cardiogenic shock. Our findings also provide insights into the characteristics of patients who died after an episode of cardiogenic shock to whom targeted surveillance and therapeutic efforts might be directed.
Conclusions:
Our findings indicate improving trends in the hospital prognosis associated with cardiogenic shock. Given the high death rates associated with this clinical complication, monitoring future trends in the incidence and death rates and the factors associated with an increased risk for developing cardiogenic shock remains warranted. 8
Differential Clinical Outcomes Associated With Hypoglycemia and Hyperglycemia in Acute Myocardial Infarction
Summary: Hyperglycemia is a strong predictor of mortality in patients hospitalized with acute myocardial infarction. Professional society guidelines have accordingly advised glucose control in hyperglycemic patients. These same guidelines also recommend avoiding hypoglycemia, even though the association between hypoglycemia and adverse outcomes in acute myocardial infarction patients is controversial. We conducted a post hoc analysis of data from 2 large trials of glucose-insulin-potassium infusion in acute myocardial infarction and compared the prognostic significance of hypoglycemia and hyperglycemia with normoglycemia in 30 536 patients. Both hypoglycemia (glucose Յ60 mg/dL) and hyperglycemia (glucose Ն140 mg/dL) at admission predicted higher 30-day mortality. However, this U-shaped relationship became attenuated in the 24-hour postadmission period, during which hyperglycemia still predicted death but hypoglycemia no longer was prognostic. Results were similar in patients with a history of diabetes. Furthermore, even though hypoglycemia was more common in patients receiving insulin (glucose-insulin-potassium) therapy than in patients who did not, hypoglycemia did not predict death in either insulin-treated or untreated patients. This study suggests that hypoglycemia may not be a direct mediator of adverse outcomes in acute myocardial infarction patients and provides some reassurance to clinicians who are concerned about overlooking or unintentionally inducing hypoglycemia in these patients.
Conclusions:
Both admission and postadmission hyperglycemia predict 30-day death in acute myocardial infarction patients. In contrast, only hypoglycemia on admission predicted death, and this relationship dissipated after admission. These data suggest hypoglycemia may not be a direct mediator of adverse outcomes in acute myocardial infarction patients. 9
Relation Between Alkaline Phosphatase, Serum Phosphate, and All-Cause or Cardiovascular Mortality
Summary: Recent reports have shown that vascular calcification and markers of mineral metabolism such as higher levels of serum phosphate are associated with adverse outcomes among people with normal kidney function. These findings have prompted examination of the link between vascular calcification, mineral metabolism, and symptomatic vascular disease in the general population. Alkaline phosphatase (AlkP) catalyzes the hydrolysis of organic pyrophosphate, an inhibitor of vascular calcification. Two recent articles reported a strong independent association between AlkP and the risk of adverse outcomes in patients with kidney failure. The authors speculated that this association was due to abnormal bone metabolism, perhaps mediated by vascular calcification, which is common among dialysis patients. We first studied people with a prior history of myocardial infarction who were free of kidney failure at baseline. We then validated findings from this first data set in an independent, nationally representative sample of the general US population. We found a graded, independent relation between higher levels of AlkP and all-cause mortality that was consistent in both the derivation and validation samples. The excess risk of death was present in people without evidence of kidney disease and was particularly high among people with higher levels of both AlkP and serum phosphate. Future studies should identify factors that are associated with higher levels of AlkP and evaluate the possibility of a causal link to vascular calcification.
Conclusions:
We found an independent relation between higher levels of AlkP and adverse outcomes among survivors of myocardial infarction and in a general population sample. The excess risk of death was present in people without evidence of kidney disease and was particularly high among people with higher levels of both AlkP and serum phosphate. 10
Metabolic Syndrome, Inflammation, and Risk of Symptomatic Peripheral Artery Disease in Women: A Prospective Study
Summary: The metabolic syndrome (MetS) is associated with myocardial infarction and stroke and is linked with subclinical inflammation. We conducted a prospective cohort study among 27 111 women free of baseline cardiovascular disease to evaluate the relationship between MetS, inflammation, and incident peripheral artery disease. We found that MetS was associated with a significantly increased risk of peripheral artery disease after multivariable adjustment (hazard ratio 1.48, 95% confidence interval 1.01-2.18), similar to previously documented associations between MetS and coronary disease or stroke; however, when inflammatory biomarkers were added to multivariable models, risk associated with MetS was attenuated and was no longer significant. Our findings were comparable in women who were nondiabetic at baseline. Taken together, our data provide evidence that MetS confers an increased risk of incident peripheral artery disease among initially healthy women and that this increased risk is largely mediated through the effects of inflammation and endothelial activation.
Conclusions: MetS is associated with an increased risk of future symptomatic peripheral artery disease in women. This risk appears to be mediated largely by the effects of inflammation and endothelial activation. 11
Plasma Vitamin B 6 and Risk of Myocardial Infarction in Women
Summary: Vitamin B 6 is a cofactor for Ͼ100 human enzymes, some of which are of importance to the cardiovascular system. Previous studies suggest that vitamin B 6 is related to cardiovascular disease. We used a matched case-control design nested within a prospective cohort study to evaluate the relationship between plasma vitamin B 6 and subsequent myocardial infarction in predominantly postmenopausal women. We found that plasma vitamin B 6 is inversely predictive of subsequent myocardial infarction in this cohort, a relationship that is stronger in younger compared with older women. A number of nondietary factors, including body mass index, are correlated to and may affect plasma B 6 concentration. Future studies are needed to better understand both dietary and nondietary determinants of plasma and tissue vitamin B 6 status and their role in the prevention of myocardial infarction and other chronic diseases.
Conclusions: Fasting plasma concentration of pyridoxal phosphate was inversely associated with myocardial infarction risk, an effect that was in part independent of dietary B 6 intake. In addition to dietary vitamin B 6 intake, there are other determinants of plasma vitamin B 6 status, and these factors warrant further research. 12
Peripheral Arterial Disease Is Associated With Higher Rates of Hip Bone Loss and Increased Fracture Risk in Older Men
Summary: Fractures related to osteoporosis and peripheral arterial disease are major causes of morbidity and mortality in older people. Previous large observational studies have provided evidence of an association between bone loss and either incident cardiovascular disease or subclinical atherosclerosis. Evidence also exists to support an association between atherosclerosis of peripheral vessels and osteoporosis. Using the ankle-brachial index and initial and repeat hip bone mineral density in a cohort of community-dwelling men 65 years of age and older in the Osteoporotic Fractures in Older Men (MrOS) study, we found that men with peripheral arterial disease have higher rates of hip bone loss and an increased risk of nonspine fractures. These findings suggest that peripheral arterial disease should be added to the list of secondary medical conditions that are associated with a greater likelihood of higher rates of bone loss and fracture among older people. Future research should examine potential biological mechanisms underlying this association.
Conclusions:
In community-dwelling older men, peripheral arterial disease was associated with higher rates of hip bone loss and increased risk of nonspine fractures. Further research should examine the biological mechanisms underlying the association between reduced limb blood flow and fractures. 13
Air Temperature and the Occurrence of Myocardial Infarction in Augsburg, Germany
Summary: Acute myocardial infarctions (MIs) often have an unexplained origin in subjects with underlying medically recognized or unrecognized vulnerability. Several factors have been identified as being associated with the onset of acute MI, including heavy exercise or physical exertion, diet, coffee and alcohol consumption, sexual activity, cocaine or marijuana abuse, emotional stress, and air pollution. Extreme ambient air temperature levels and temperature changes have been hypothesized to be acute risk factors for cardiovascular disease, particularly MI. In this study, we examined the relationship between air temperature and daily numbers of MI and coronary deaths over a 10-year period from 1995 to 2004. The Monitoring Trends and Determinants on Cardiovascular Diseases/ Cooperative Health Research in the Region of Augsburg (MONICA/ KORA) MI registry recorded 9801 events occurring in patients 25 to 74 years of age. A 10°C decrease in 5-day average temperature was associated with a 10% risk increase (95% confidence interval, 1.04 -1.15) for total MI events. An effect of heat was not observed in this temperate climate. Fatal and nonfatal events, but not recurrent events, were associated with cold temperatures. No difference was observed for men and women. Subjects 55 to 74 years of age, but not younger patients, seemed to be affected. Risks associated with cold temperatures were more pronounced in years with higher average temperatures and occurred during the summer, which argues against an effect of extreme temperature levels. Our results suggest that unusual temperature decreases or individually felt cold can increase the risk for an acute event and should be considered a transient risk factor for MI.
Conclusions:
We observed an inverse relationship between temperature and MI occurrence not only during winter but also during summer. Thus, our results suggest not a pure "cold effect" but an influence of unusual temperature decreases. 14
Associations of Gestational Weight Gain With Offspring Body Mass Index and Blood Pressure at 21 Years of Age: Evidence From a Birth Cohort Study
Summary: Routine measurement of maternal weight during pregnancy is controversial. The practice was abandoned in many countries in the late 1990s because it was found to be a poor indicator of intrauterine growth retardation. However, this position is now being reconsidered as emerging evidence suggests that greater weight gain in pregnancy might indicate those women who are at increased risk of future cardiovascular and metabolic disease and may be a risk factor for future offspring health. In this study, we examined the association of maternal weight gain in pregnancy with offspring body mass index and blood pressure at 21 years of age. We found that greater weight gain during pregnancy was independently associated with greater risk for offspring body mass index and obesity. We also found some evidence that this association with greater body mass index might result in greater offspring systolic blood pressure. This study supports other evidence suggesting that excessive pregnancy weight gain should be avoided for the health of both mother and offspring. Further large studies are required to confirm these findings and to determine what should be considered healthy weight gain for the short-and long-term health of both mother and offspring. Ultimately, trials are required to explore whether routine monitoring of weight gain in pregnancy and provision of advice about healthy weight gain are effective at reducing obesity-related outcomes in mothers and offspring in the long term.
Conclusions: Our findings show that greater gestational weight gain is associated with greater offspring body mass index into early adulthood and that this may translate into higher systolic blood pressure in offspring. Further large studies are required to confirm an effect of gestational weight gain on a range of offspring cardiovascular risk factors. 15
Relations of Lipid Concentrations to Heart Failure Incidence: The Framingham Heart Study
Summary: Heart failure has increased in prevalence in recent decades. Dyslipidemia has been suspected of influencing heart failure risk, but few community-based epidemiological studies addressed this issue. Because the development of heart failure portends an increased burden of morbidity and mortality, it is important to understand the risk factors for this condition so that preventative strategies can be developed. In participants free of coronary heart disease at baseline, we evaluated prospectively the relations of high-density lipoprotein cholesterol (HDL-C) and non-HDL-C concentrations to heart failure incidence. We related both baseline and periodically updated lipid concentrations to heart failure incidence after adjustment for clinical covariates and interim occurrence of myocardial infarction. We observed a consistent positive relation of baseline and periodically updated non-HDL-C concentrations and an inverse relation of HDL-C concentrations to heart failure incidence. The relations of HDL-C and non-HDL-C to heart failure risk were statistically significant even after adjustment for interim myocardial infarction. Dyslipidemia (elevated non-HDL-C [Ն190 mg/dL] or low HDL-C [Ͻ40 mg/dL in men and Ͻ50 mg/dL in women]) explained 22.5% of heart failure occurrence. Our findings are consistent with the hypothesis that dyslipidemia increases heart failure risk independent of its association with myocardial infarction. Our data highlight a possible mechanism for the decrease in heart failure incidence noted in several trials of lipid-modification therapy and suggest that lipid modification may be a means of preventing heart failure.
Conclusions: Dyslipidemia carries heart failure risk independent of its association with myocardial infarction, suggesting that lipid modification may be a means for reducing heart failure risk. 16 
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Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC)
Summary: We present prospective findings of cardiovascular autonomic neuropathy (CAN) in patients with type 1 diabetes mellitus enrolled in the Diabetes Control and Complications Trial (DCCT) and followed up annually through the Epidemiology of Diabetes Interventions and Complications (EDIC) for an additional 13 to 14 years after the DCCT closeout. CAN is associated with a high risk of cardiac arrhythmias and sudden death, possibly related to silent myocardial ischemia. Our study provides a comprehensive CAN assessment over 25 years in a well-characterized cohort of patients with type 1 diabetes mellitus. The prevalence and incidence of CAN, as assessed by heart rate variability, increased substantially from DCCT closeout to EDIC year 13/14 despite the young age of the cohort, a very low prevalence of CAN at DCCT closeout, and good glycemic control. Even after adjustment for the level or presence of CAN at DCCT closeout, there were persistent beneficial effects of prior intensive versus conventional therapy after 13 to 14 years of follow-up in EDIC. Treatment group differences in the mean level of hemoglobin A 1c during DCCT and EDIC explained virtually all of the beneficial effects of intensive versus conventional therapy on risk of incident CAN. These findings support the recommendation that intensive treatment of type 1 diabetes mellitus be initiated as early as possible to provide durable protection from the development and progression of diabetic complications.
Conclusions:
Although CAN prevalence increased in both groups, the incidence was significantly lower in the former intensive group compared with the former conventional group. The benefits of former intensive therapy extend to measures of CAN up to 14 years after DCCT closeout. 17
Plasma Asymmetrical Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community
Summary: The endothelium plays a major role in regulating vascular tone by secreting the potent vasodilator nitric oxide, which is synthesized from L-arginine (Arg) by endothelial nitric oxide synthase. Nitric oxide synthase is competitively inhibited by asymmetrical dimethylarginine (ADMA), an endogenous compound that is elevated in renal failure, cardiovascular disease, and diabetes mellitus. Higher ADMA and low ratio of Arg to ADMA are markers of endothelial dysfunction. Prospective investigations have highlighted the role of ADMA as a predictor of cardiovascular disease events and death in patients with coronary artery disease, renal failure, and other high-risk conditions. Data are limited regarding the relations of ADMA and Arg/ADMA ratio to cardiovascular disease incidence and death in the general population. We related plasma ADMA, Arg, and the Arg/ADMA ratio to the incidence of cardiovascular disease and death in 3320 participants from the community-based Framingham study cohort who were followed up for 10.9 years. In multivariable models adjusting for established risk factors, ADMA was associated positively with death, whereas the Arg/ADMA ratio was inversely related. We noted effect modification by diabetes status; ADMA was associated with death in individuals without diabetes but not in individuals with diabetes. ADMA and the Arg/ADMA ratio were not associated with cardiovascular disease incidence. Additional studies evaluating a larger sample of individuals (including those with diabetes) and with longer follow-up are warranted to confirm these observations.
Conclusions:
In our large community-based sample, ADMA was significantly associated with all-cause mortality, particularly in nondiabetic individuals. 18
Four Blood Pressure Indexes and the Risk of Stroke and Myocardial Infarction in Japanese Men and Women: A Meta-Analysis of 16 Cohort Studies
Summary: Information has been sparse on the comparison of 4 blood pressure (BP) indexes (systolic BP, diastolic BP, pulse pressure, and mean BP) in relation to long-term incidence of stroke and myocardial infarction, particularly in middle-aged and older Asians. The present meta-analysis of 16 cohort studies investigated Ͼ1000 stroke events and 200 myocardial infarction events from Ͼ400 000 person-years of follow-up in middle-aged and older Japanese men and women. For predicting all stroke, ischemic stroke, and myocardial infarction, mean BP or systolic BP was generally the strongest and pulse pressure was the weakest in any of the age-sex groups. For hemorrhagic stroke, mean BP was the strongest predictor in both sexes, and in men, diastolic BP was more important than systolic BP. Pulse pressure was not the strongest of the 4 BP indexes for any subtype of stroke in any of the age-sex groups, including older people. For the primary prevention of cardiovascular diseases in East Asian populations, the long-term risk of stroke and myocardial infarction should be assessed mainly by systolic BP. Diastolic BP should also be given careful consideration for its independent relationship to stroke risk. Emphasis on pulse pressure should be avoided even in older people for the prediction of future cardiovascular disease risk. Although mean BP was important in addition to systolic BP, use of this index may not be practical in daily clinical and public health practice at present.
Conclusions:
The long-term incident risk of stroke and myocardial infarction associated with high BP in East Asian populations should be assessed mainly on the basis of systolic blood pressure. Mean blood pressure also may be an important predictor, but pulse pressure is a less important predictor for cardiovascular disease risk. 19
Association of Circulating Cholesteryl Ester Transfer Protein Activity With Incidence of Cardiovascular Disease in the Community
Summary: Inhibiting cholesteryl ester transfer protein (CETP) activity raises high-density lipoprotein cholesterol levels and may be cardioprotective. However, an initial clinical trial with a CETP inhibitor was stopped prematurely because of increased cardiovascular disease (CVD) events in treated patients. Data relating circulating CETP mass to CVD incidence in the community are also conflicting. Therefore, we related routinely assayed plasma CETP activity to the incidence of CVD events on follow-up (average, 15 years) in the offspring cohort of the Framingham Heart Study. In multivariable analyses adjusted for standard CVD risk factors, plasma CETP activity was related inversely to the incidence of CVD events, a finding that remained robust in time-dependent models updating CVD risk factors every 4 years on follow-up and was maintained in analyses of incident "hard" CVD events. These observational data based on prospective follow-up of a large community-based sample require confirmation. If confirmed, our findings would call into question the use of CETP inhibition as a strategy for lowering CVD risk.
Conclusions:
In our prospective investigation of a community-based sample, lower plasma CETP activity was associated with greater CVD risk. These observations, if confirmed, challenge the concept that CETP inhibition may lower CVD risk. 20
Anthropometry, Body Fat, and Venous Thromboembolism: A Danish Follow-Up Study
Summary: The distribution of body fat predicts the risk of coronary heart disease, and central obesity consistently has been shown to be a risk factor for coronary heart disease, whereas peripheral obesity (measured as high hip circumference) appears to protect against coronary heart disease. The importance of fat distribution with regard to the risk of venous thromboembolism (VTE), ie, deep venous thrombosis and pulmonary embolism, has not been evaluated. In a 10-year follow-up study of 56 014 middle-aged men and women, which included 641 verified incident events of VTE, we evaluated the risk of VTE according to different measurements of fat distribution in the body. Our results show that all measurements of obesity are positively associated with VTE in both sexes. We also showed that a higher hip circumference in normal-weight persons was associated with a higher risk for VTE, which is in contrast to studies on coronary heart disease. We found statistically significant positive associations between idiopathic (unprovoked) VTE and all measurements of obesity. The associations between VTE and the anthropometric measurements persisted after adjustment for hypertension, diabetes mellitus, or hypercholesterolemia, which shows that the effect of obesity was not mediated solely by these factors.
Conclusions: All measurements of obesity are predictors of the risk for VTE. Positive associations were found between VTE and body weight, body mass index, waist circumference, hip circumference, and total body fat mass. 21
Joint Effects of Physical Activity, Body Mass Index, Waist Circumference, and Waist-to-Hip Ratio on the Risk of Heart Failure
Summary: In a prospective cohort of 59 178 Finnish participants who were 25 to 74 years of age and free of heart failure (HF) at baseline, we evaluated the single and joint associations of physical activity and different indicators of adiposity (body mass index, waist circumference, and waist-to-hip ratio) with HF risk. During a mean follow-up of 18.4 years, 1921 men and 1693 women developed HF. The multivariable-adjusted hazard ratios of HF associated with low, moderate, and high physical activity were 1.00, 0.79, and 0.69 (P trend Ͻ0.001) for men and 1.00, 0.86, and 0.68 (P trend Ͻ0.001) for women, respectively. The multivariable-adjusted hazard ratios of HF at different levels of body mass index (Ͻ25, 25-29.9, and Ն30) were 1.00, 1.25, and 1.99 (P trend Ͻ0.001) for men, and 1.00, 1.33, and 2.06 (P trend Ͻ0.001) for women, respectively. Abdominal adiposity, measured by waist circumference or waist-to-hip ratio, was associated with a greater risk of HF among both men and women (all P trend Ͻ0.01). In joint analyses, the protective effect of physical activity was consistent in subjects at all levels of body mass index.
Our study confirms that general overweight and general and abdominal obesity are independently associated with an increased risk of HF, whereas moderate or high levels of physical activity are associated with a reduced risk of HF. To combat the epidemic of overweight/obesity and to improve cardiovascular health at a population level, it is important to develop strategies to increase habitual physical activity and to prevent obesity in collaboration with communities.
Conclusions: General overweight and general and abdominal obesity are independently associated with an increased risk of HF, whereas moderate or high levels of physical activity are associated with a reduced risk of HF. The protective effect of physical activity on HF risk is observed at all levels of body mass index. 22
Relations of Matrix Remodeling Biomarkers to Blood Pressure Progression and Incidence of Hypertension in the Community
Summary: The biomarkers of extracellular matrix remodeling include matrix metalloproteinases (which break down collagen), tissue inhibitors of metalloproteinases (which inhibit the activity of metalloproteinases), and procollagen peptides (which reflect the turnover of extracellular collagen). We evaluated 595 middle-age, nonhypertensive Framingham Offspring Study participants without prior heart failure or myocardial infarction who had measured blood levels of tissue inhibitor of metalloproteinase-1 (TIMP-1), matrix metalloproteinase-9 (MMP-9), and procollagen III N-terminal peptide. We related matrix biomarker levels prospectively to the incidence of hypertension and the progression of blood pressure (BP) to a higher category (as defined by the sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure). On follow-up (4 years), 81 participants developed hypertension, and 198 (114 women) progressed to a higher BP category. After adjustment for standard risk factors for hypertension, higher tissue inhibitor of metalloproteinase-1 levels and detectable matrix metalloproteinase-9 both were associated with longitudinal tracking of BP. Individuals in the top tertile of tissue inhibitor of metalloproteinase-1 had a 2.15-fold increased risk of hypertension (relative to the lowest tertile), whereas those with detectable matrix metalloproteinase-9 had a nearly 2-fold increased risk of BP progression compared with those with undetectable levels. Plasma procollagen III N-terminal peptide was not associated with BP tracking.
Overall, these data suggest that higher circulating levels of select matrix remodeling biomarkers may predate the onset of hypertension, perhaps because they reflect ongoing vascular remodeling that accompanies the evolution of high BP.
Conclusions: In the present community-based sample, higher TIMP-1 and MMP-9 concentrations were associated with BP progression on follow-up. Additional studies are warranted to confirm our findings. 23
Lifetime Fruit and Vegetable Consumption and Arterial Pulse Wave Velocity in Adulthood: The Cardiovascular Risk in Young Finns Study
Summary: The primary prevention of cardiovascular diseases should be started in childhood because the atherosclerotic process develops silently for decades before clinical events such as myocardial infarction or stroke occur. Epidemiological studies have shown that it may be possible to modify cardiovascular disease risk by favorable lifestyle changes (eg, healthy diet, adequate physical activity, smoking restriction). However, a limited amount of information is available on childhood lifestyle risk factors and cardiovascular disease risk in adulthood. The Cardiovascular Risk in Young Finns Study is an ongoing 5-center follow-up study of atherosclerosis risk factors in Finnish children and adolescents. Participants were followed up since 1980 and had lifestyle risk factor data since childhood (3-18 years). Arterial pulse wave velocity was determined in young adulthood (aged 30 -45 years) because it is a marker of arterial stiffness and an independent predictor of cardiovascular events and all-cause mortality. We showed that high fruit and vegetable consumption was associated with lower pulse wave velocity. The decrease in pulse wave velocity was more evident if the consumption of fruits and vegetables remained high from childhood to adulthood. It is also important to modify all lifestyle risk factors (low fruit consumption, low vegetable consumption, low physical activity, and smoking) in childhood because multiple risk factors led to increased arterial stiffness in this study. These findings highlight the importance of emphasizing lifestyle as early as in childhood in the primary prevention of cardiovascular disease.
Conclusions: These findings suggest that lifetime lifestyle risk factors, with low consumption of fruits and vegetables in particular, are related to arterial stiffness in young adulthood. 24
Perceived Level of Life Enjoyment and Risks of Cardiovascular Disease Incidence and Mortality: The Japan Public Health Center-Based Study
Summary: Although relationships between negative psychological conditions and risk of cardiovascular disease incidence and mortality have been well documented, little is known about associations between positive psychological conditions and the risk of disease. Perceived level of life enjoyment, a positive psychological condition that reflects the ability to engage pleasurably with the environment, may relate to risks of cardiovascular disease. This community-based prospective study of
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Ϸ90 000 Japanese 40 to 69 years of age showed that lower sense of life enjoyment was associated with higher risks of cardiovascular disease incidence and mortality. The multivariable hazard ratios of cardiovascular disease incidence for men in the low versus high perceived levels of life enjoyment group were 1.22 (95% confidence interval, 1.01-1.47) for stroke and 1.23 (95% confidence interval, 1.05-1.44) for total cardiovascular disease. As for mortality, Japanese men with low perceived level of life enjoyment showed increased risk: hazard risks of 1.75 (95% confidence interval, 1.28 -2.38) for stroke, 1.91 (95% confidence interval, 1.30 -2.81) for coronary heart disease, and 1.61 (95% confidence interval, 1.32-1.96) for total cardiovascular disease.
The inverse association did not change substantially when cardiovascular deaths that occurred after the first to sixth year from baseline were excluded. For women, perceived level of life enjoyment was not associated with risks of cardiovascular disease incidence and mortality. Our findings suggest a protective role of positive psychological conditions on cardiovascular disease among middle-aged men.
Conclusion:
A lower perceived level of life enjoyment was found to be associated with higher risks of cardiovascular disease incidence and mortality among middle-aged men, suggesting a protective role of positive psychological conditions on cardiovascular disease. 25
Prognostic Value of Changes in the Electrocardiographic Strain Pattern During Antihypertensive Treatment: The Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE)
Summary: This study demonstrates that development of a new ECG strain pattern of lateral ST depression and T-wave inversion in lead V 5 or V 6 between baseline and year 1 during the LIFE study (Losartan Intervention For End-point reduction in hypertension) identifies patients at increased risk of cardiovascular morbidity and mortality, sudden cardiac death, and all-cause mortality in the setting of antihypertensive therapy associated with substantial decreases in both systolic and diastolic pressure. The increased risk associated with new ECG strain was independent of the improved prognosis with losartan therapy and with regression of ECG left ventricular hypertrophy in the LIFE study and persisted after adjustment for the greater baseline severity and prevalence of ECG left ventricular hypertrophy and the higher prevalence of other cardiovascular disorders associated with ECG strain. The independent relation of new ECG strain to increased risk in the LIFE study despite aggressive blood pressure reduction suggests that the development of new strain on the ECG may be used to identify hypertensive patients with ECG left ventricular hypertrophy who require more aggressive antihypertensive therapy aimed at further risk reduction. Further research will be required to determine whether additional treatment in patients with new ECG strain will improve prognosis in this high-risk group of hypertensive patients.
Conclusions: Development of new ECG strain is associated with an increased risk of cardiovascular morbidity and mortality and of all-cause mortality in the setting of antihypertensive therapy and regression of ECG left ventricular hypertrophy. 26
Perioperative Risk Predictors of Cardiac Outcomes in Patients Undergoing Liver Transplantation Surgery
Summary: Liver transplantation surgery has become widespread, but knowledge of the appropriate perioperative cardiac risk assessment of this patient population remains limited. Current literature is controversial and clinical outcomes data are lacking. We evaluated the largest cohort to date to better define cardiac risk and to identify prognostic markers for those patients undergoing liver transplantation surgery. The present clinical study should help lead to a standardized approach to cardiac risk evaluation of patients undergoing a liver transplantation surgery. This, in turn, should lead to better patient outcomes and improved resource allocation. Several areas are controversial, including the role of preoperative noninvasive stress testing, use of perioperative ␤-blockers, surgical risk, and identification of variables that can be associated with adverse cardiac outcomes. We found that perioperative ␤-blocker use was protective from adverse cardiac outcomes. Furthermore, noninvasive stress testing was most useful for identifying a low-risk group of patients with a very high negative predictive value. History of coronary disease, stroke, increased interventricular septal thickness, and postoperative sepsis were all associated with adverse cardiac outcomes. Current models of risk assessment underestimate these patients, and our study suggests that they do not fit the traditional model and are likely at a higher risk for perioperative cardiac events. This study has helped clarify many of the clinical issues and should provide a strong foundation to develop future prospective randomized trials.
Conclusion:
In our study of cardiac risk assessment for liver transplantation surgery, history of stroke, coronary artery disease, postoperative sepsis, and increased interventricular septal thickness were markers of adverse perioperative cardiac outcomes, whereas use of perioperative ␤-blockers was significantly protective. 27
Relation of Platelet and Leukocyte Inflammatory Transcripts to Body Mass Index in the Framingham Heart Study
Summary: There have been many genetic epidemiology and biomarker studies examining associations of common genetic variants (DNA) and circulating proteins with clinically apparent cardiovascular disease and associated risk factors; however, there has been relatively little study of gene expression or transcriptomics. Quantitative differences in the abundance of transcripts (messenger RNA) has been demonstrated in specific malignancies, but gene expression from a large communitybased cohort examining cardiovascular disease or its risk factors has never been reported. In this study, we measured quantitative expression of 48 genes in 1846 participants of the Framingham Offspring cohort from RNA derived from isolated platelets and leukocytes. Specific inflammatory platelet-derived transcripts were significantly associated with higher body mass index. Compared with platelets, fewer leukocytederived transcripts were associated with body mass index or other cardiovascular risk factors. Select transcripts were found to be highly heritable. This study demonstrates that inflammatory transcripts derived from platelets, particularly those part inflammatory regulating pathways, are associated with BMI, whereas other distinct transcripts, many known to be related to platelet function, are heritable. This is the first study, using a large community-based cohort, to demonstrate that quantitative gene expression is associated with risk factors, most notably body mass index.
Conclusions: Inflammatory transcripts derived from platelets, particularly those part of the nuclear factor B pathway, are associated with BMI, whereas others are heritable. This is the first study, using a large community-based cohort, to demonstrate clinical correlates of gene expression and is consistent with the hypothesis that specific peripheral-blood transcripts play a role in the pathogenesis of coronary heart disease and its risk factors. 28 apoB levels were measured in 1831 black, 1047 white, and 603 Hispanic subjects in the Dallas Heart Study. OxPL/apoB levels were highest in blacks, followed by whites and Hispanics, and did not correlate with any traditional risk factors except Lp(a). The highest correlation between OxPL/apoB and Lp(a) was present in blacks, followed by whites and Hispanics; was dependent on apolipoprotein(a) [apo(a)] isoform size; and became progressively weaker with larger isoforms. The size of the major apo(a) isoform (number of kringle type IV repeats) was negatively associated with OxPL/apoB regardless of racial/ethnic group. This study demonstrates that elevated OxPL/apoB levels are associated with both small apo(a) isoforms and high Lp(a), which explains the differences in racial/ethnic groups, which have genetic differences in both apo(a) and Lp(a) levels. The association of OxPL with small apo(a) isoforms, in which a similar relationship is present among all racial/ ethnic subgroups despite differences in Lp(a) levels, may be a key determinant of cardiovascular risk.
Relationship of Oxidized Phospholipids on Apolipoprotein B-100 Particles to Race/Ethnicity, Apolipoprotein(a) Isoform Size, and Cardiovascular Risk Factors: Results From the Dallas Heart Study
Conclusions: OxPL/apoB levels vary according to race/ethnicity, are largely independent of cardiovascular risk factors, and are inversely associated with apo(a) isoform size. The association of OxPL with small apo(a) isoforms, in which a similar relationship is present among all racial/ethnic subgroups despite differences in Lp(a) levels, may be a key determinant of cardiovascular risk. 29
A Prospective Study of Bone Lead Concentration and Death From All Causes, Cardiovascular Diseases, and Cancer in the Department of Veterans Affairs Normative Aging Study
Summary: Genetics is well known to play only a limited role in the pathogenesis of cardiovascular disease. It is now known that in addition to diet, exercise, and other lifestyle and behavioral factors, certain environmental risk factors play a significant role in the general population. Much attention has been paid recently to particulate air pollution and secondhand cigarette smoke as such risk factors, for example. This study builds on another body of research recently indicating that cumulative environmental lead exposure (from decades of exposures to lead in combusted gasoline, paint, water, and food cans) is a risk factor for hypertension and myocardial infarction and goes even farther by linking such exposure directly to increased prospective cardiovascular mortality. Like a number of other recent studies, this investigation also shows that the risk to individuals posed by lead exposure cannot be captured adequately by measuring blood lead levels, which primarily signifies recent, rather than cumulative, exposure. From a clinical perspective, this research highlights the importance of incorporating at least a brief environmental/occupational assessment in the conduct of preventive cardiology and medicine and of advocating for the elimination or minimization of activities that are associated with lead exposure. It also underscores the anticipation surrounding an ongoing National Institutes of Health-funded multicenter trial testing the potential value of chelation in reducing cardiovascular risks, the results of which remain pending.
Conclusions:
We found bone lead to be associated with all-cause and cardiovascular mortality in an environmentally exposed population with low blood lead levels. This study suggests that cumulative lead exposure from prior decades of high environmental exposures continues to significantly affect risk of death despite recent declines in environmental lead exposure. 30
Plasma Copeptin and the Risk of Diabetes Mellitus
Summary: Despite the fact that diabetes mellitus is a potent risk factor for cardiovascular morbidity and mortality, therapies focused on lowering plasma glucose have not been convincingly shown to reduce cardiovascular mortality. Thus, identifying drug-modifiable factors other than glucose that link diabetes mellitus to cardiovascular disease is important. Copeptin, a stable fragment of the vasopressin precursor, has been studied in risk prediction in myocardial infarction and congestive heart failure. Vasopressin is known to affect liver glycogenolysis, insulin, and glucagon secretion and pituitary adrenocorticotropin hormone release. Here, we show in a large prospective cohort study that an increased copeptin level in plasma predicts future diabetes mellitus independently of known risk factors. In nondiabetic individuals, the top versus bottom quartile of copeptin the risk of diabetes mellitus was increased Ͼ2-fold; among individuals with normal fasting glucose, the risk was increased 3.5-fold. Our data suggest that plasma copeptin may be valuable for diabetes risk assessment, especially in subjects without impaired fasting glucose, and point to a new pharmacologically modifiable system of potential importance in both diabetes mellitus and cardiovascular disease.
Conclusions: Elevated copeptin predicts increased risk for diabetes mellitus independently of established clinical risk factors, including fasting glucose and insulin. These findings could have implications for risk assessment, novel antidiabetic treatments, and metabolic side effects from arginine vasopressin system modulation. 31
Urinary Creatinine Excretion Rate and Mortality in Persons With Coronary Artery Disease: The Heart and Soul Study
Summary: Recent studies have demonstrated that low body mass index is associated with mortality in individuals with coronary artery disease, whereas higher body mass index is not. Lower body mass index may reflect low muscle mass rather than low fat. When serum creatinine is in steady state, urinary creatinine excretion rate is proportional to muscle mass. In 903 outpatients with stable coronary artery disease, we collected 24-hour urine collections and evaluated the relation of creatinine excretion rate with mortality over 6 years. Individuals within the lowest tertile of creatinine excretion rate were at Ͼ2-fold mortality risk compared with the highest tertile independently of body mass index, waist-to-hip ratio, traditional coronary artery disease risk factors, inflammatory biomarkers, and kidney function. Timed urine collection may provide an inexpensive and readily available method to measure muscle mass in outpatients with coronary artery disease and to garner additional information on mortality risk independently of conventional measures of body composition or traditional coronary artery disease risk factors. Future studies are required to determine whether resistive exercise and/or nutritional interventions can improve creatinine excretion rate and whether such improvements in creatinine excretion rate are associated with demonstrable improvements in health outcomes.
Conclusions: Lower creatinine excretion rate is strongly associated with mortality in outpatients with coronary artery disease, independently of conventional measures of body composition, kidney function, and traditional coronary artery disease risk factors. Future studies should determine whether low creatinine excretion rate may be a modifiable risk factor for mortality among persons with coronary artery disease, potentially through resistive exercise training or nutrition interventions. 32
Hemodynamic Correlates of Blood Pressure Across the Adult Age Spectrum: Noninvasive Evaluation in the Framingham Heart Study
Summary: Blood pressure increases substantially and nonlinearly with age across the adult lifespan. Mean arterial pressure and pulse wave velocity increase and pulse pressure decreases before 50 years of age, whereas systolic and pulse pressures and pulse wave velocity increase markedly thereafter, at a time when the prevalence of hypertension and cardiovascular disease is high. The pathogenesis of nonlinear age trajectories of blood pressure components has been debated vigorously in recent years, with some suggesting that elevated pulse wave velocity and premature wave reflection account for the increase in pulse pressure. We found that forward wave amplitude is the predominant hemodynamic correlate of pulse pressure across the adult age spectrum and accounts for an overwhelming majority of the accelerated increase in pulse pressure after 50 years of age. Differences in relative wave reflection contribute modestly to variability in pulse pressure, whereas reflected wave timing plays a minimal role. Differing age relations of pulse wave velocity and pulse pressure, which were divergent before 50 years of age and concordant thereafter, suggest that alterations in aortic diameter may modulate changes in pulse pressure in the face of changes in wall stiffness and pulse wave velocity. Additional studies are needed to define the mechanisms that contribute to aortic wall stiffening with advancing age and risk factor exposure and to clarify the role of aortic diameter. A fuller understanding of the pathogenesis of increased pulse pressure and systolic hypertension is needed and will facilitate development of more rational approaches to the treatment of hypertension.
Conclusions: Higher pulse pressure at any age and higher pulse pressure with advancing age is associated predominantly with a larger forward pressure wave. The influence of wave reflection on age-related differences in pulse pressure was minor. 33
Emergency Hospital Admissions for Cardiovascular Diseases and Ambient Levels of Carbon Monoxide: Results for 126 United States Urban Counties, 1999 to 2005
Summary: With growing traffic in many urban centers, the health impacts of traffic-related air pollution are a current public health concern. This national study of 126 US urban counties during 1999 to 2005 examines whether exposure to carbon monoxide (CO) on the same day and previous few days increases risk of cardiovascular disease (CVD) hospitalizations for an older population based on Ͼ9.3 million Medicare enrollees aged Ն65 years. Our findings indicate that higher levels of CO exposure are associated with an increased risk of CVD hospitalizations on the same day for multiple cause-specific CVD outcomes (ischemic heart disease, heart rhythm disturbances, heart failure, cerebrovascular disease, and total CVD admissions). Although it is not possible to fully disentangle the effects of CO and of other air pollutants produced by traffic, the association between CO and CVD hospital admissions remained after adjustment for other traffic-related pollutants: NO 2 , fine particulate matter (with aerodynamic diameter Յ2.5 m) total mass, and elemental carbon. The risk persisted even at low CO levels Ͻ1 ppm, which are well below the current US health-based regulatory standard. This study provides one of the first population-based investigations of the health effects of current low ambient CO levels and indicates that exposure to current CO levels may still pose a threat to public health, particularly for persons with CVD. It adds to other research showing that air pollution harms the health of people with CVD.
Conclusions:
We found evidence of an association between shortterm exposure to ambient CO and risk of CVD hospitalizations, even at levels well below current US health-based regulatory standards. This evidence indicates that exposure to current CO levels may still pose a public health threat, particularly for persons with CVD. 34
Longitudinal Tracking of Left Ventricular Mass Over the Adult Life Course: Clinical Correlates of Short-and Long-Term Change in the Framingham Offspring Study
Summary: Clinically overt heart failure is the end point of a long disease continuum characterized by progressive structural and functional changes of the heart, a dynamic process referred to as cardiac remodeling. Considering the current burden of heart failure and the projected increase over the next 50 years, it is critical to understand factors that influence cardiac remodeling over the adult life course. Using longitudinal data from the Framingham Offspring cohort (up to 4 serial routine echocardiographic observations on each individual, with 11 762 observations in total) and multilevel statistical modeling, we identified age, sex, body mass index, systolic blood pressure, antihypertensive treatment, smoking, and diabetes mellitus as key correlates of longitudinal tracking of left ventricular mass, an important cardiac remodeling phenotype. Women and participants with diabetes mellitus experienced a steeper increase in left ventricular mass with advancing age (compared with men and those without diabetes mellitus). Women also displayed a greater increase in left ventricular mass with increasing body mass index (compared with men). Participants with optimal values of these cardiovascular risk factors experienced lesser increases in left ventricular mass over time. Analyses evaluating short-term (4-year) changes in left ventricular mass (2605 unique individuals providing 4494 observations) identified the same key determinants that influenced its long-term trajectory (ie, body mass index, sex, systolic blood pressure, antihypertensive treatment, and smoking). These observations are consistent with the notion that maintenance of optimal levels of these risk factors in young to midlife will reduce the burden of left ventricular hypertrophy, and possibly heart failure, in older age.
Conclusions: Our longitudinal observations on a large communitybased sample identified higher blood pressure, excess adiposity, smoking, and diabetes mellitus as fundamental determinants of LV mass tracking over the adult life course. These observations are consistent with the notion that maintenance of optimal levels of these risk factors in midlife will reduce the burden of LV hypertrophy, and possibly heart failure, in older age. 35
Influence of Age on Associations Between Childhood Risk Factors and Carotid Intima-Media Thickness in Adulthood: The Cardiovascular Risk in Young Finns Study, the Childhood Determinants of Adult Health Study, the Bogalusa Heart Study, and the Muscatine Study for the International Childhood Cardiovascular Cohort (i3C) Consortium
Summary: The pediatric origin of atherosclerosis is now well accepted, with several authorities issuing guidelines and consensus statements for the assessment and management of cardiovascular disease risk factors, including lipids and lipoprotein, blood pressure, and adiposity, in childhood. Despite this, there have been scant data that have assessed the optimal age when childhood risk exposure begins to associate with adult atherosclerosis, and thus the optimal age for risk factor screening.
In the present analyses based on 4 population-based, prospective childhood cohorts-the Cardiovascular Risk in Young Finns Study (Finland), the Childhood Determinants of Adult Health study (Australia), the Bogalusa Heart Study (United States), and the Muscatine Study (United States)-we examined the influence of age on the associations between childhood risk factors and adult carotid artery intima-media thickness, a subclinical marker of atherosclerosis, among 4380 participants 3 to 18 years old at baseline who were reexamined 13 to 28 years later. On the basis of our findings, risk factors measured before the age of 9 years had only weak or nonsignificant associations with carotid intima-media thickness measured more than 20 years later, whereas analysis among subjects 9 to 18 years of age showed significant associations between childhood risk exposure and increased adult intima-media thickness. Our data have direct clinical and public health importance because they suggest that risk factor screening from the age of 9 years onward allows youth who are at increased risk of subclinical atherosclerosis in adulthood to be identified. However, care providers need to keep in mind that although the optimal age for pediatric risk factor screening may commence at 9 years of age, primordial prevention of cardiovascular disease should begin earlier in the life course.
Conclusions: Our analyses from 4 longitudinal cohorts showed that the strength of the associations between childhood risk factors and carotid intima-media thickness is dependent on childhood age. On the basis of these data, risk factor measurements obtained at or after 9 years of age are predictive of subclinical atherosclerosis in adulthood. 36
Parental Occurrence of Stroke and Risk of Stroke in Their Children: The Framingham Study
Summary: The Framingham Heart Study has prospectively verified data on the occurrence of stroke across 2 generations of participants, the original (parental) and offspring cohorts. We studied incident stroke risk among 3443 stroke-free offspring (53% female; mean age, 48Ϯ14 years) with verified parental stroke status (by 65 years of age). Using multivariable Cox models adjusted for age, sex, sibship, and baseline stroke risk factors, we observed that over a period of 77 534 personyears, verified parental stroke by 65 years of age resulted in a nearly 3-fold independent increase in risk of offspring stroke (hazard ratio, 2.79; 95% confidence interval, 1.68 -4.66; PϽ0.001 for all stroke; and hazard ratio, 3.15; 95% confidence interval, 1.69 -5.88; PϽ0.001 for ischemic stroke). This was true for both maternal and paternal stroke. The increased risk persisted after adjustment for conventional stroke risk factors. Thus, parental stroke status might serve as a simple, clinically useful, aggregate measure of an individual's hereditary propensity to stroke. It has been suggested that for many polygenic diseases and traits, testing for multiple risk alleles may not improve on the use of family history as a risk marker.
Conclusions: Documented parental stroke by 65 years of age was associated with a 3-fold increase in risk of offspring stroke. This increased risk persisted after adjustment for conventional stroke risk factors. Thus, verified parental stroke may serve as a clinically useful risk marker of an individual's propensity to stroke. 37
Homoarginine, Cardiovascular Risk, and Mortality
Summary: Evidence suggests that homoarginine, a cationic acid formed from lysine, may impact nitric oxide metabolism, endothelial function, and insulin secretion, all of which are relevant for the maintenance of cardiovascular health. In the present study, the association of circulating homoarginine concentrations with cardiovascular outcomes and with mortality was assessed in 2 separate large cohorts: 3305 subjects referred for coronary angiography (LUdwigshafen RIsk and Cardiovascular Health [LURIC] study) and 1244 diabetic patients undergoing maintenance hemodialysis (Die Deutsche Diabetes Dialyze Studie [4D] study). Low blood homoarginine concentration was strongly associated with death in both cohorts. In the LURIC population, persons with values of blood homoarginine in the lowest quartile had a more than 3-fold higher cardiovascular mortality than those with levels in the highest quartile after adjustment for other known vascular risk factors. Circulating homoarginine levels were markedly lower in hemodialysis patients (4D population), who overall had a 5-fold greater mortality than patients referred for coronary angiography. In the dialysis patients, a similar association between lower homoarginine quartiles and greater mortality was seen. With the 2 independent cohorts, which evaluated a diverse spectrum of patients, the present study demonstrates a consistent, strong association of homoarginine with cardiovascular and all-cause mortality and suggests important new avenues for future research.
Conclusions: Homoarginine levels are independently associated with cardiovascular and all-cause mortality in patients referred for coronary angiography and in patients undergoing hemodialysis. Future studies are needed to elucidate the underlying pathomechanisms. 38
Correlates of Echocardiographic Indices of Cardiac Remodeling Over the Adult Life Course: Longitudinal Observations From the Framingham Heart Study
Summary: The human heart undergoes dynamic, incremental alterations in structure and function over the lifespan, a phenomenon referred to as cardiac remodeling. Examination of the course and correlates of cardiac remodeling in aging adults is critical for elucidating the pathways by which older age predisposes to cardiac dysfunction, particularly heart failure, in the setting of a preserved ejection fraction. Using longitudinal data collected from participants in the Framingham Offspring Study (up to 4 serial echocardiographic observations per individual, totaling 11 485 observations) and multilevel statistical modeling, we observed that left ventricular (LV) cavity dimensions (end-systolic more than end-diastolic) decreased with advancing age, whereas LV wall thickness and fractional shortening increased. Women and individuals with diabetes mellitus experienced greater ageassociated increases in LV wall thickness. However, the presence of diabetes or a higher blood pressure level was associated with a lesser decrease in LV dimensions with older age. Similarly, treatment with antihypertensive medication was a marker of an attenuated increase in fractional shortening with aging. Together, these findings indicate that cardiac remodeling over the adult life course is characterized by a distinct pattern of increasing LV wall thickness, decreasing LV dimensions, and increasing fractional shortening with advancing age. Notably, female sex, greater blood pressure load, and presence of diabetes serve to attenuate this remodeling pattern. Overall, these observations suggest a mechanism by which women with hypertension and individuals with diabetes may be particularly predisposed to heart failure with a preserved ejection fraction in later life.
Conclusions:
Cardiac remodeling over the adult life course is characterized by a distinct pattern of increasing LV wall thickness, decreasing LV dimensions, and increasing fractional shortening with advancing age. Overall, female sex, greater blood pressure load, and presence of diabetes mellitus serve to attenuate this remodeling pattern. These observations suggest a mechanism for the preponderance of women with hypertension and individuals with diabetes among patients with diastolic heart failure. 39
Hypertension in Pregnancy and Later Cardiovascular Risk: Common Antecedents?
Summary: Gestational hypertension and preeclampsia are common disorders in pregnancy, and both disorders have been associated with a substantially increased risk of cardiovascular disease later in life. Therefore, hypertension in pregnancy may provide a unique opportunity for the clinicians to identify women at an early stage who may be at increased risk of future cardiovascular disease. It is uncertain, however, whether the association of hypertensive pregnancy disorders with cardiovascular disease can be attributed to factors that operate in pregnancy or to prepregnancy factors that are associated with both the pregnancy condition and later cardiovascular disease. We linked data from the Medical Birth Registry of Norway to 2 waves of a large population-based health survey in Norway (the Nord-Trøndelag Health Study [HUNT]) and prospectively examined the association of hypertensive disorders in Ͼ3225 pregnancies with subsequent measurements of body mass index, blood pressure, and serum levels of high-density lipoprotein cholesterol and triglycerides; we simultaneously adjusted for prepregnancy measurements of the same factors. We found that the associations of hypertensive disorders in pregnancy with subsequent body mass index and blood lipids were considerably attenuated after adjustment for risk factors measured before pregnancy. The results of this study suggest that the positive association of preeclampsia and gestational hypertension with later unfavorable cardiovascular risk factors may be due largely to shared prepregnancy risk factors such as obesity, dyslipidemia, and elevated blood pressure rather than reflecting factors that can be attributed to the hypertensive pregnancy.
Conclusions: These results suggest that the positive association of preeclampsia and gestational hypertension with postpregnancy cardiovascular risk factors may be due largely to shared prepregnancy risk factors rather than reflecting a direct influence of the hypertensive disorder in pregnancy. 40
Neighborhood Socioeconomic Context and Long-Term Survival After Myocardial Infarction
Summary: Neighborhood of residence has been suggested to affect cardiovascular risk over and above personal socioeconomic status
The Editors Most Read in Epi and Prevention, Part II e529 (SES) . However, such data are currently lacking for patients with myocardial infarction (MI). We examined long-term survival according to neighborhood SES in a cohort of myocardial infarction patients. Consecutive patients (nϭ1179) Յ65 years of age discharged from 8 hospitals in central Israel after incident (ie, first ever) myocardial infarction in 1992 to 1993 were followed up for a median of 13 years. Personal socioeconomic and clinical data were obtained at study entry. Neighborhood SES was estimated through a composite census-derived index developed and validated by the Israel Central Bureau of Statistics. Neighborhood SES was strongly related to survival in a dose-response manner; patients residing in disadvantaged neighborhoods had higher mortality rates. Adjustment for personal SES measures and established prognostic factors attenuated the association, yet excess risk persisted for living in a disadvantaged neighborhood. The association was even stronger with regard to cardiac mortality. In the final fully adjusted models, several personal SES measures, including education, employment, and living with a steady partner, as well as neighborhood socioeconomic context, were concurrently associated with all-cause and cardiac mortality. Thus, our data support a multidimensional relationship between SES and myocardial infarction survival and indicate the importance of enhancing preventive/rehabilitative healthcare services for post-myocardial infarction patients residing in deprived neighborhoods. Further research is needed to identify the most relevant features of residential environments that affect cardiovascular incidence and prognosis.
Conclusions: Neighborhood SES is strongly associated with longterm survival after MI. The association is partly, but not entirely, attributable to individual SES and clinical characteristics. These data support a multidimensional relationship between SES and MI outcome. 41
Myocardial Infarction and Risk of Suicide: A Population-Based Case-Control Study
Summary: Myocardial infarction (MI) is associated with an increased risk of anxiety, depression, low quality of life, and all-cause mortality. Whether MI is associated with an increased risk of suicide is unknown. We conducted a population-based case-control study by retrieving data from 5 nationwide longitudinal registers in Denmark. As cases, we selected all persons aged 40 to 89 years who died by suicide from 1981 to 2006. As controls, we randomly selected up to 10 persons per case matched by sex, day of birth, and calendar time. We identified 19 857 persons who committed suicide and 190 058 controls. We found that MI was associated with a marked increased risk of suicide. The risk of suicide was highest within the first month after discharge for MI for patients with no history of psychiatric illness (adjusted rate ratio, 3.25; 95% confidence interval, 1.61-6.56) and for patients with a history of psychiatric illness (adjusted rate ratio, 64.05; 95% confidence interval, 13.36 -307.06) compared with those with no history of MI or psychiatric illness. However, the risk remained high for at least 5 years after MI and when adjusted for stroke, diabetes mellitus, and socioeconomic factors. Our results suggest the importance of screening patients with MI for depression and suicidal ideation.
Conclusions: MI is followed by an increased risk of suicide for persons with and without psychiatric illness. Our results suggest the importance of screening patients with MI for depression and suicidal ideation. 42
Association Between Kidney Function and Albuminuria With Cardiovascular Events in HIV-Infected Persons
Summary: Cardiovascular disease is now a leading cause of death in HIV-infected persons. In recognition of the need to improve the quality of cardiovascular disease care in HIV infection, the American Heart Association recently convened a panel of experts to identify urgent clinical issues and research challenges facing this population. During this conference, the need to identify characteristics that will aid in cardiovascular disease risk stratification was designated as a research priority. We conducted this study to describe the association between markers of kidney disease-estimated glomerular filtration rate and albuminuria-and cardiovascular events in HIV-infected persons. To address this question, we used a national registry of HIV-infected persons receiving care in the Veterans Health Administration, which is the largest provider of HIV care in the United States. Both estimated glomerular filtration rate and albuminuria were strongly associated with the risk of incident cardiovascular disease (defined as coronary, cerebrovascular, and peripheral arterial disease) and heart failure in a graded, independent manner. In addition, both markers provided complementary prognostic information. In contrast to many novel risk factors, estimated glomerular filtration rate and albuminuria are already recommended for chronic kidney disease screening in all patients at diagnosis of HIV and annually in high-risk groups. Therefore, our findings may have immediate clinical application in aiding clinicians to risk stratify HIV-infected persons for future cardiovascular events and provide rationale for interventional studies aimed at treatment of kidney disease or reduction of albuminuria.
Conclusions:
In this national sample of HIV-infected persons, estimated glomerular filtration (eGFR) and albuminuria levels were strongly associated with risk of cardiovascular disease and heart failure. Kidney function and albuminuria provide complementary prognostic information that may aid cardiovascular disease risk stratification in HIV-infected persons. 43
Bleeding Increases the Risk of Ischemic Events in Patients With Peripheral Arterial Disease
Summary: In patients with coronary artery disease or cerebrovascular disease and antithrombotic treatment, bleeding significantly increases the risk of subsequent ischemic events. Although patients with peripheral arterial disease have the same risk of ischemic events as patients with coronary artery disease or cerebrovascular disease and often use antithrombotics, this association has not previously been demonstrated in peripheral arterial disease patients. To gain insight into the consequences of bleeding in all patients at risk, the effect of bleeding was studied in patients who received oral anticoagulation or aspirin after peripheral bypass surgery in a large multicenter randomized trial, the Dutch Bypass and Oral Anticoagulants or Aspirin (BOA) Study. Nonfatal major bleeding was found to be a strong and independent predictor for the composite event of nonfatal myocardial infarction, nonfatal ischemic stroke, major amputation, or cardiovascular death (adjusted hazard ratio, 3.0; 95% confidence interval, 1.9 -4.7). These first data in patients with peripheral arterial disease are in line with growing evidence of the adverse outcome of nonfatal bleeding in patients across the spectrum of atherosclerotic disease. The net clinical benefit of antithrombotic treatment in atherosclerotic patients depends on the subtle balance between the prevention of ischemic events and the inherent risk of bleeding. With bleeding increasing the risk of ischemic events, this balance is more complicated than previously considered and underlines the importance of optimal antithrombotic therapy with optimal risk management.
Measures to achieve this include use of low-dose aspirin and gastrointestinal protection if needed, improved treatment compliance, and maintenance of optimal anticoagulant intensity.
Conclusions:
In patients with peripheral arterial disease, as in patients with coronary artery disease or cerebrovascular disease, major bleeding was independently associated with major ischemic complications. Without compromising the benefits of antithrombotics, these findings call for caution relative to the risks of major bleeding. 44 early atherosclerosis and have been found to predict cardiovascular events. Preclinical atherosclerosis is a reversible, dynamic process. Different interventions on cardiovascular risk factors (dyslipidemia, hypertension, diabetes mellitus, and obesity) have been shown to slow or even regress atherosclerosis. However, the reversibility of ultrasonographic preclinical vascular changes associated with metabolic syndrome recovery is unknown. Our results from a population-based study of young adults (nϭ1673; age, 24 -39 years at baseline) suggest that arterial structure and function are restored after spontaneous recovery from the metabolic syndrome. Furthermore, recovery from the metabolic syndrome was associated with weight loss, increased physical activity, and favorable changes in blood pressure, lipids, glucose, and insulin. Therefore, major efforts are needed for the reduction of overweight and an increase in physical activity, particularly in young adults with the metabolic syndrome to reduce the risk of cardiovascular disease later in their life.
Conclusion: Recovery from the MetS was associated with positive effects on vascular properties during a 6-year follow-up period of young adults. 45
Aortic Root Remodeling Over the Adult Life Course: Longitudinal Data From the Framingham Heart Study
Summary: Our study provides longitudinal community-based data on tracking of aortic root size over 16 years in mid to late adulthood. The aortic root gradually enlarges over the life course and is principally related to age, sex, body size, and blood pressure. These factors interact in a complex fashion in their associations with aortic root remodeling. In particular, obese individuals with hypertension show the greatest dilatation, whereas women display less aortic root dilatation than men. Furthermore, separate components of hemodynamic load differed in their relation with aortic root size: Steadyflow load (mean arterial pressure) was positively associated with aortic root diameter, whereas pulsatile load (pulse pressure) was inversely associated with aortic root diameter. The underlying basis for these differences and implications for the development of cardiovascular events deserve further study.
Conclusions: These longitudinal community-based data show that aortic root remodeling occurs over mid to late adulthood and is principally associated with age, sex, body size, and blood pressure. The underlying basis for these differences and implications for the development of cardiovascular events deserve further study. 46
Longitudinal Tracking of Left Atrial Diameter Over the Adult Life Course: Clinical Correlates in the Community
Summary: Preventing atrial fibrillation (AF) is a public health priority in light of the high lifetime risk for this condition, the projected increase in population burden, and the substantial morbidity and mortality associated with the disease. Increased left atrial diameter (LAD), a marker of left atrial remodeling, is associated with elevated risk of AF (new onset and recurrent). This association has led to the hypothesis that increased LAD may represent an intermediate phenotype in the progression from risk factors to AF, especially in older individuals. Information is limited, however, on short-and long-term clinical correlates of LAD across the adult life course. In this investigation of a large, community-based sample, we used multilevel modeling to evaluate correlates of LAD during a 16-year period and also related these risk factors to short-term change in LAD (during a 4-year period). We identified higher blood pressure and greater body mass index as key correlates of both short-term LAD change and long-term tracking of LAD. Using sex-specific growth curves for LAD, we also observed that LAD at baseline and over time was positively associated with greater risk factor burden.
The results of our study suggest that maintenance of optimal levels of blood pressure and body mass during adulthood may be critical for preventing atrial remodeling and AF.
Conclusions: Our longitudinal study of a large community-based sample identified higher blood pressure and greater body mass index as key modifiable correlates of LAD, suggesting that maintaining optimal levels of these risk factors through the life course may prevent atrial remodeling and AF. 47
Association of Leukocyte Telomere Length With Echocardiographic Left Ventricular Mass: The Framingham Heart Study
Summary: Leukocyte telomere length (LTL) decreases over the adult life course owing to the cumulative burden of oxidative stress, inflammation, and exposure to vascular risk factors. Left ventricular (LV) mass is a biomarker of long-standing exposure to cardiovascular disease risk factors. We hypothesized, therefore, that LTL is related inversely to echocardiographic LV mass and examined this association in a moderate-sized community-based sample. However, in multivariable analyses, we observed an association that was opposite in directionality to that hypothesized: LTL was positively related to LV mass and LV wall thickness. We observed effect modification by hypertension status, with a stronger association of LTL with LV mass and LV wall thickness in individuals with hypertension. These data raise the possibility that longer LTL may be a marker of propensity to LV hypertrophy. Additional studies are warranted to confirm these observations.
Conclusions:
In contrast to our expectation, in the present community-based sample, LTL was positively associated with LV mass and wall thickness, especially so in participants with hypertension. These data are consistent with the hypothesis that longer LTL may be a marker of propensity to LV hypertrophy. 48
Attained Educational Level and Incident Atherothrombotic Events in Low-and Middle-Income Compared With High-Income Countries
Summary: Atherothrombotic diseases (coronary heart disease, cerebrovascular disease, and peripheral arterial disease) are the leading cause of death worldwide. Attained educational level is a socioeconomic indicator that strongly predicts cardiovascular outcomes. However, most studies reporting this association have been conducted in high-income countries (HICs), with very little representation from low-and middle-income countries (LMICs), which bear Ͼ80% of the world's cardiovascular deaths. In the global Reduction of Atherothrombosis for Continued Health (REACH) Registry, 61 332 clinic outpatients with either established atherothrombotic disease or multiple atherothrombotic risk factors were recruited from 44 countries from both LMIC and HIC regions. Self-reported attained educational level (the number of years of formal education completed) and cardiovascular risk factors were documented at baseline, and patients were followed up longitudinally for 23 months for incident atherothrombotic events. Educational attainment was inversely associated with age and diabetes mellitus and directly associated with hypercholesterolemia in all subjects. However, for other risk factors such as obesity, smoking, hypertension, and baseline burden of vascular disease, attained educational level was protective (inversely associated) in HICs but not protective in LMICs. The protective association between higher attained educational level and incident cardiovascular events was strongest in men from HICs, more modest in men from LMICs and in women from HICs, and essentially absent in women from LMICs.
These results indicate that studies that report a protective association between attained educational level and cardiovascular outcomes in HICs do not extrapolate to LMICs, especially in women. Further studies dedicated to LMIC settings are essential to investigate the The Editors Most Read in Epi and Prevention, Part II e531 association between socioeconomic indicators and cardiovascular outcomes in these regions.
Conclusion:
In contrast to HICs, higher attained educational levels may not be protective against cardiovascular events in LMICs, particularly in women. 49
Pathophysiological Changes in Calf Muscle Predict Mobility Loss at 2-Year Follow-Up in Men and Women With Peripheral Arterial Disease
Summary: Men and women with lower extremity peripheral arterial disease (PAD) have smaller calf muscle area, lower calf muscle density, and increased calf muscle percent fat compared with people without PAD. However, the prognostic significance of these calf muscle changes in PAD is unclear. This observational, prospective study measured calf muscle area, calf muscle density, and calf muscle percent fat with the use of computed tomography in 370 participants with PAD. At 2-year follow-up, participants with lower baseline calf muscle area, lower baseline calf muscle density, and higher baseline calf muscle percent fat had higher rates of mobility loss. These findings also suggest that interventions to prevent mobility loss in PAD should focus on reversing pathophysiological findings in calf muscle.
Conclusions: Our findings suggest that interventions to prevent mobility loss in peripheral arterial disease should focus on reversing pathophysiological findings in calf muscle. 50
Exhaled Carbon Monoxide and Risk of Metabolic Syndrome and Cardiovascular Disease in the Community
Summary: Carbon monoxide (CO) is widely recognized as a potentially toxic byproduct of hydrocarbon combustion. More recently, CO has been recognized as a key second messenger molecule that is normally present in the body at low concentrations and serves to protect the cardiovascular system against oxidative, inflammatory, and vascular stresses. Thus, elevated levels of endogenous CO may reflect the presence of underlying metabolic and cardiovascular pathology. We assessed the association of exhaled CO (a marker of endogenous CO) with the presence of cardiometabolic risk factors cross-sectionally and with the risk of developing future metabolic syndrome and overt cardiovascular disease prospectively among 4139 individuals (contributing 14 943 person-examinations) in the Framingham Heart Study. We observed that exhaled CO was associated with the presence of metabolic syndrome (Pϭ0.01) in addition to many of its component risk factors. During up to 4 years of follow-up, baseline CO was also associated with future cardiometabolic events, with individuals in the highest quartile of exhaled CO having a Ϸ1.5 odds of developing metabolic syndrome (PϽ0.0001) and Ϸ1.7 risk of developing cardiovascular disease (Pϭ0.008) compared with the lowest quartile, serving as referent. Overall, the findings of this study suggest that elevated CO is an important marker for the development of both metabolic disease and cardiovascular disease. Additional research is warranted to elucidate how CO-related pathways may contribute to cardiometabolic disorders and their associated outcomes.
Conclusion:
In our community-based sample, higher exhaled CO levels predicted the development of metabolic syndrome and future cardiovascular disease events, underscoring the importance of this endogenous second messenger in the pathogenesis of metabolic and vascular risk. 51 
